NCT07581002
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07581002
Title A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) (REVIVAL)
Acronym REVIVAL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ISR

Facility Status City State Zip Country Details
Mayo Clinic Hospital - Phoenix /ID# 282904 NOT_YET_RECRUITING Phoenix Arizona 85054 United States Details
City of Hope National Medical Center /ID# 279568 RECRUITING Duarte California 91010 United States Details
Mayo Clinic Hospital Jacksonville /ID# 282903 NOT_YET_RECRUITING Jacksonville Florida 32224 United States Details
Montefiore Medical Center - Moses Campus /ID# 279399 RECRUITING The Bronx New York 10467 United States Details
Tel Aviv Sourasky Medical Center /ID# 278717 RECRUITING Tel Aviv Tel Aviv 6423906 Israel Details
Rambam Health Care Campus- Haifa /ID# 278719 RECRUITING Haifa 3109601 Israel Details
Shaare Zedek Medical Center /ID# 278712 RECRUITING Jerusalem 9103102 Israel Details
Hadassah Medical Center-Hebrew University /ID# 278866 RECRUITING Jerusalem 91120 Israel Details
Samsung Medical Center /ID# 279397 RECRUITING Seoul Seoul Teugbyeolsi 06351 South Korea Details
China Medical University Hospital /ID# 279261 RECRUITING Taichung 40447 Taiwan Details
Taichung Veterans General Hospital /ID# 279296 RECRUITING Taichung 407 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field